311690 — CJ Bioscience Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSucker Stock

Annual cashflow statement for CJ Bioscience, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-8,763	-19,272	-34,913	-22,913	-32,838
Depreciation
Amortisation
Non-Cash Items	837	10,278	3,138	-8,002	144
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-1,104	-1,005	6,883	870	613
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-7,978	-8,437	-20,993	-24,899	-27,760
Capital Expenditures	-18,866	-979	-4,870	-16,417	-584
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-7,640	7,431	12,035	33,116	-66,974
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-26,506	6,453	7,165	16,699	-67,557
Financing Cash Flow Items	—	—	-250	-261	-312
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	42,345	50,711	1,022	22,944	39,499
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	7,901	48,805	-12,737	14,772	-55,786